Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 2/20 | 0.37 |
| ▸ | CCR8 | P51685 | 2/20 | 0.37 |
| ▸ | TRPV3 | Q8NET8 | 3/20 | 0.36 |
| ▸ | METAP2 | P50579 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | ALPL | P05186 | 1/20 | 0.30 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
| ▸ | ALPI | P09923 | 1/20 | 0.30 |
| ▸ | ALPG | P10696 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | CCR5 | P51681 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | NOS1 | P29475 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26886755 | 0.93 | TGFBR1 (0.33) | CCR1CCR8TRPV3KCNH2 | |
| SCHEMBL26788249 | 0.91 | TLR7 (0.32) | CCR1CCR8TRPV3NOS1NOS2 | |
| SCHEMBL1465458 | 0.90 | KCNH2 (0.38) | KCNH2NOS1NOS2 | |
| SCHEMBL15329105 | 0.88 | KDM4E (0.52) | CCR1CCR8METAP2KDM4ELMNA | |
| Hydrochloric Acid SCHEMBL28145952 | 0.88 | KCNH2 (0.36) | KCNH2NOS1NOS2 | |
| SCHEMBL25015292 | 0.85 | GABRA1 (0.33) | TRPV3LMNA | |
| SCHEMBL17696699 | 0.84 | — | — | |
| SCHEMBL1466621 | 0.82 | KCNH2 (0.33) | KCNH2 | |
| SCHEMBL1467560 | 0.82 | KCNH2 (0.33) | KCNH2 | |
| SCHEMBL1465789 | 0.82 | KCNH2 (0.33) | KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9463451-B2 | Ligand, metal complex containing ligand, and reaction using metal complex containing ligand | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2016-10-11 | — | — | US | disclosed |
| US-9463451-B2 | Ligand, metal complex containing ligand, and reaction using metal complex containing ligand | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2016-10-11 | — | — | US | disclosed |
| US-20160107151-A1 | LIGAND, METAL COMPLEX CONTAINING LIGAND, AND REACTION USING METAL COMPLEX CONTAINING LIGAND | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2016-04-21 | — | — | US | disclosed |
| US-20160107151-A1 | LIGAND, METAL COMPLEX CONTAINING LIGAND, AND REACTION USING METAL COMPLEX CONTAINING LIGAND | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2016-04-21 | — | — | US | disclosed |
| EP-2966081-A1 | LIGAND, METAL COMPLEX CONTAINING LIGAND, AND REACTION USING METAL COMPLEX CONTAINING LIGAND | National University Corporation Nagoya University (JP) | 2016-01-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160107151-A1 | LIGAND, METAL COMPLEX CONTAINING LIGAND, AND REACTION USING METAL COMPLEX CONTAINING LIGAND | HRH3, HRH2, HRH4 | CCR1 621/4885CCR8 1289/4885TRPV3 1713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.